Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Cancer. 2010 May 1;116(9):2180–2187. doi: 10.1002/cncr.25028

Table 3.

Risk Factors by Response Group


CR/nPR N (%)
Not CR/nPR N (%)
P value
TFS Estimate months (95% CI)
Log rank p value
Age
    < 70 13 (54%) 11 (46%) 0.05 15.8 (11.2-23.7) 0.13
    ≥ 70
1 (11%)
8 (89%)

14.8 (6.5-18.9)

CD38
    Negative (≤ 30) 10 (48%) 11 (52%) 0.49 15.8 (11.2-23.7) 0.43
    Positive (>30)
4 (33%)
8 (67%)

20.6 (5.0- 20.6)

Zap 70 *
    Negative (≤ 20) 5 (31%) 11 (69%) 0.47 15.7 (13.6-15.9) 0.26
    Positive (>20)
8 (50%)
8 (50%)

20.6 (10.8-25.5)

Ig VH Mutation **
    Unmutated 5 (42%) 7 (58%) 1.0 15.9 (6.5-23.7) 0.66
    Mutated
9 (47%)
10 (53%)

15.7 (10.8 - 18.9)

FISH***
    Low/Intermediate Risk 13 (50%) 13 (50%) 15.9 (15.7-23.7)
    High Risk 1 (14%) 6 (86%) 0.20a 10.8 (3.2-18.9) 0.01a
    Del(11q22.3) 1(17%) 5(83%) 0.20b 7.9 (3.2-13.6) 0.001b
*

Zap missing one observation

**

Mutation missing two observations

***

FISH low/intermediate risk: del (13q14), trisomy (+) 12, or normal; FISH high risk: del(17p13.1) or del(11q22.3).

a

p-values for low/intermediate risk vs. high risk ((del(17p13.1) or del(11q22.3))

b

p-values for low/intermediate risk vs. del(11q22.3) alone